Compounds > kynurenine

kynurenine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

kynurenine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schapira, AH1
Acuña-Castroviejo, D; Camacho, E; Carrión, MD; Doerrier, C; Escames, G; Espinosa, A; López, LC; Mora, F; Tapias, V1

Reviews

1 review(s) available for kynurenine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
The use of toxins to elucidate neural function and disease.
    Current opinion in neurology and neurosurgery, 1993, Volume: 6, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Brain; Brain Diseases; Disease Models, Animal; Humans; Huntington Disease; Kynurenine; Neurotoxins; Parkinson Disease, Secondary; Quinolinic Acid

1993

Other Studies

1 other study(ies) available for kynurenine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
    Brain research bulletin, 2011, May-30, Volume: 85, Issue:3-4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Cytosol; Disease Models, Animal; Drug Administration Schedule; Kynurenine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; MPTP Poisoning; NAD; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Oxidation-Reduction; Substantia Nigra

2011